tiprankstipranks

Pennant Group price target raised to $23 from $22 at Stephens

Stephens raised the firm’s price target on Pennant Group to $23 from $22 and keeps an Overweight rating on the shares. CMS released proposed Medicare Hospice provider rate updates for FY25 at +2.6%, reflecting a +$705M projected increase in overall payments, the analyst tells investors in a research note. The proposed FY25 rates compare to final and proposed FY2024 rates of +3.1% and +2.8%, respectively.

Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>

Disclaimer & DisclosureReport an Issue